Swedbank AB raised its position in shares of Welltower Inc. (NYSE:WELL - Free Report) by 11.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 666,219 shares of the real estate investment trust's stock after purchasing an additional 66,039 shares during the period. Swedbank AB owned about 0.10% of Welltower worth $102,418,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Good Life Advisors LLC increased its holdings in shares of Welltower by 1.2% in the first quarter. Good Life Advisors LLC now owns 5,744 shares of the real estate investment trust's stock valued at $880,000 after purchasing an additional 69 shares during the period. Rise Advisors LLC increased its holdings in shares of Welltower by 23.3% in the first quarter. Rise Advisors LLC now owns 365 shares of the real estate investment trust's stock valued at $56,000 after purchasing an additional 69 shares during the period. Sivia Capital Partners LLC increased its holdings in shares of Welltower by 4.3% in the first quarter. Sivia Capital Partners LLC now owns 1,783 shares of the real estate investment trust's stock valued at $273,000 after purchasing an additional 73 shares during the period. Sound View Wealth Advisors Group LLC increased its holdings in shares of Welltower by 2.0% in the first quarter. Sound View Wealth Advisors Group LLC now owns 3,644 shares of the real estate investment trust's stock valued at $558,000 after purchasing an additional 73 shares during the period. Finally, Premier Path Wealth Partners LLC increased its holdings in shares of Welltower by 1.8% in the first quarter. Premier Path Wealth Partners LLC now owns 4,427 shares of the real estate investment trust's stock valued at $678,000 after purchasing an additional 77 shares during the period. 94.80% of the stock is owned by institutional investors.
Analysts Set New Price Targets
WELL has been the topic of a number of recent research reports. Raymond James Financial restated a "strong-buy" rating on shares of Welltower in a research note on Tuesday, September 2nd. Scotiabank upped their target price on Welltower from $172.00 to $181.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Wells Fargo & Company upped their target price on Welltower from $175.00 to $185.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. Evercore ISI upped their target price on Welltower from $175.00 to $183.00 and gave the stock an "in-line" rating in a research note on Monday, September 15th. Finally, UBS Group initiated coverage on Welltower in a research note on Friday. They issued a "buy" rating and a $195.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $177.55.
View Our Latest Research Report on Welltower
Insider Transactions at Welltower
In related news, Director Andrew Gundlach bought 20,000 shares of the firm's stock in a transaction that occurred on Monday, June 30th. The stock was purchased at an average cost of $151.46 per share, for a total transaction of $3,029,200.00. Following the completion of the acquisition, the director owned 20,000 shares in the company, valued at approximately $3,029,200. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.21% of the company's stock.
Welltower Trading Down 0.6%
WELL stock traded down $1.00 during midday trading on Friday, hitting $165.53. 20,205,185 shares of the company's stock were exchanged, compared to its average volume of 2,294,890. The business has a 50-day simple moving average of $165.11 and a two-hundred day simple moving average of $154.88. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $110.71 billion, a PE ratio of 93.52, a P/E/G ratio of 1.86 and a beta of 0.93. Welltower Inc. has a 1-year low of $122.34 and a 1-year high of $171.09.
Welltower (NYSE:WELL - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The real estate investment trust reported $1.28 EPS for the quarter, topping the consensus estimate of $1.22 by $0.06. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The business had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.49 billion. During the same period last year, the business posted $1.05 earnings per share. The company's quarterly revenue was up 39.6% on a year-over-year basis. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, sell-side analysts predict that Welltower Inc. will post 4.88 EPS for the current fiscal year.
Welltower Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, August 21st. Stockholders of record on Tuesday, August 12th were given a dividend of $0.74 per share. This is an increase from Welltower's previous quarterly dividend of $0.67. This represents a $2.96 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Welltower's dividend payout ratio (DPR) is 167.23%.
Welltower Profile
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Recommended Stories

Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.